Find Pimecrolimus manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

17RELATED EXCIPIENT COMPANIES

34EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Elidel, 137071-32-0, Sdz-asm 981, Sdz-asm-981, Sdz asm 981, 33-epi-chloro-33-desoxyascomycin
Molecular Formula
C43H68ClNO11
Molecular Weight
810.4  g/mol
InChI Key
KASDHRXLYQOAKZ-XDSKOBMDSA-N
FDA UNII
7KYV510875

Pimecrolimus
Pimecrolimus is a 33-epi-chloro-derivative of the ascomycin macrolactam with immunosuppressant property. Pimecrolimus binds to the receptor macrophilin-12 (FKBP-12) forming a complex that blocks the calcium-dependent signal transduction cascade mediated by calcineurin. Via dephosphorylation, calcineurin is the enzyme responsible for activating nuclear factor of activated T-cells (NF-AT), a T cell transcriptional regulatory factor. As a consequence, the synthesis and release of Th1- (T helper 1) and Th2- (T helper 2) type cytokines, and other inflammatory mediators from T-cells and mast cells are blocked and the expression of signals essential for the activation of inflammatory T-lymphocytes is inhibited. However, pimecrolimus mode of action is cell-selective and does not affect Langerhans' cells/dendritic cells and primary fibroblasts.
Pimecrolimus is a Calcineurin Inhibitor Immunosuppressant. The mechanism of action of pimecrolimus is as a Calcineurin Inhibitor.
1 2D Structure

Pimecrolimus

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(E)-1-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone
2.1.2 InChI
InChI=1S/C43H68ClNO11/c1-10-30-18-24(2)17-25(3)19-36(53-8)39-37(54-9)21-27(5)43(51,56-39)40(48)41(49)45-16-12-11-13-32(45)42(50)55-38(28(6)33(46)23-34(30)47)26(4)20-29-14-15-31(44)35(22-29)52-7/h18,20,25,27-33,35-39,46,51H,10-17,19,21-23H2,1-9H3/b24-18+,26-20+/t25-,27+,28+,29-,30+,31-,32-,33-,35+,36-,37-,38+,39+,43+/m0/s1
2.1.3 InChI Key
KASDHRXLYQOAKZ-XDSKOBMDSA-N
2.1.4 Canonical SMILES
CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
2.1.5 Isomeric SMILES
CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C
2.2 Other Identifiers
2.2.1 UNII
7KYV510875
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 33-epi-chloro-33-desoxyascomycin

2. Asm 981

3. Elidel

4. Sdz Asm 981

5. Sdz-asm-981

2.3.2 Depositor-Supplied Synonyms

1. Elidel

2. 137071-32-0

3. Sdz-asm 981

4. Sdz-asm-981

5. Sdz Asm 981

6. 33-epi-chloro-33-desoxyascomycin

7. Asm 981

8. 7kyv510875

9. Elidel (tn)

10. Pimecrolimus [usan:inn:ban]

11. 1000802-56-1

12. 33-epichloro-33-desoxyascomycin

13. Pimecrolimus (jan/usan/inn)

14. Unii-7kyv510875

15. Asm-981

16. Asm-998

17. Ncgc00167506-01

18. Pimecrolimus (elidel)

19. Pimecrolimus [mi]

20. (-)-pimecrolimus

21. Pimecrolimus [inn]

22. Pimecrolimus [jan]

23. Pimecrolimus [usan]

24. Pimecrolimus [vandf]

25. Pimecrolimus [mart.]

26. Pimecrolimus [who-dd]

27. Schembl438880

28. Sdz Asm-981

29. Gtpl6783

30. Schembl3000675

31. Chembl1200686

32. Pimecrolimus, >=97% (hplc)

33. Chebi:135888

34. Pimecrolimus [orange Book]

35. Ex-a2138

36. Bdbm50248356

37. Mfcd00901792

38. S5004

39. Zinc85536990

40. Akos015895946

41. Ccg-270502

42. Db00337

43. Ncgc00167506-04

44. Hy-13723

45. B1817

46. D05480

47. Ab01566841_01

48. 071p320

49. Q417489

50. Q-201579

51. Brd-k92107055-001-01-9

52. (1r,9s,12s,13r,14s,17r,18e,21s,23s,24r,25s,27r)-12-[(1e)-1-[(1r,3r,4s)-4-chloro-3-methoxycyclohexyl]prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0?,?]octacos-18-ene-2,3,10,16-tetrone

53. (3s,4r,5s,8r,9e,12s,14s,15r,16s,18r,19r,26as)-3-((e)-2-((1r,3r,4s)-4-chloro-3-methoxycyclohexyl)-1-methylvinyl)-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,26,26a-hexadecahydro-5,19-epoxy-3h-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,17,20,21(4h,23h)-tetrone

54. 15,19-epoxy-3h-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4h,23h)-tetrone, 3-((1e)-2-((1r,3r,4s)-4-chloro-3-methoxycyclohexyl)-1-methylethenyl)-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-, (3s,4r,5s,8r,9e,12s,14s,15r,16s,18r,19r,26as)-

55. 15,19-epoxy-3h-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4h,23h)-tetrone, 3-(2-(4-chloro-3-methoxycyclohexyl)-1-methylethenyl)-8-ethyl-, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-, (3s-(3r*(e(1s*,3s*,4r*)),4s*,5r*,8s*,9e,12r*,14r*,15s*,16r*,18s*,19s*,26ar*))-

2.4 Create Date
2006-05-02
3 Chemical and Physical Properties
Molecular Weight 810.4 g/mol
Molecular Formula C43H68ClNO11
XLogP33.8
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count11
Rotatable Bond Count6
Exact Mass809.4480897 g/mol
Monoisotopic Mass809.4480897 g/mol
Topological Polar Surface Area158 Ų
Heavy Atom Count56
Formal Charge0
Complexity1440
Isotope Atom Count0
Defined Atom Stereocenter Count14
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count2
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameElidel
PubMed HealthPimecrolimus (On the skin)
Drug ClassesDermatological Agent
Drug LabelELIDEL (pimecrolimus) Cream 1% contains the compound pimecrolimus, the immunosuppressant 33-epi-chloro-derivative of the macrolactam ascomycin.Chemically, pimecrolimus is (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(1E)-2-{(1R,3R,4S)-4-chl...
Active IngredientPimecrolimus
Dosage FormCream
RouteTopical
Strength1%
Market StatusPrescription
CompanyValeant Bermuda

2 of 2  
Drug NameElidel
PubMed HealthPimecrolimus (On the skin)
Drug ClassesDermatological Agent
Drug LabelELIDEL (pimecrolimus) Cream 1% contains the compound pimecrolimus, the immunosuppressant 33-epi-chloro-derivative of the macrolactam ascomycin.Chemically, pimecrolimus is (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(1E)-2-{(1R,3R,4S)-4-chl...
Active IngredientPimecrolimus
Dosage FormCream
RouteTopical
Strength1%
Market StatusPrescription
CompanyValeant Bermuda

4.2 Drug Indication

For treatment of mild to moderate atopic dermatitis.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Pimecrolimus is a chemical that is used to treat atopic dermatitis (eczema). Atopic dermatitis is a skin condition characterized by redness, itching, scaling and inflammation of the skin. The cause of atopic dermatitis is not known; however, scientists believe that it may be due to activation of the immune system by various environmental or emotional triggers. Scientists do not know exactly how pimecrolimus reduces the manifestations of atopic dermatitis, but pimecrolimus reduces the action of T-cells and mast cells which are part of the immune system and contribute to responses of the immune system. Pimecrolimus prevents the activation of T-cells by blocking the effects of chemicals (cytokines) released by the body that stimulate T-cells. Pimecrolimus also reduces the ability of mast cells to release chemicals that promote inflammation.


5.2 MeSH Pharmacological Classification

Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


Calcineurin Inhibitors

Compounds that inhibit or block the PHOSPHATASE activity of CALCINEURIN. (See all compounds classified as Calcineurin Inhibitors.)


Dermatologic Agents

Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)


Immunosuppressive Agents

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
PIMECROLIMUS
5.3.2 FDA UNII
7KYV510875
5.3.3 Pharmacological Classes
Calcineurin Inhibitors [MoA]; Calcineurin Inhibitor Immunosuppressant [EPC]
5.4 ATC Code

D - Dermatologicals

D11 - Other dermatological preparations

D11A - Other dermatological preparations

D11AH - Agents for dermatitis, excluding corticosteroids

D11AH02 - Pimecrolimus


5.5 Absorption, Distribution and Excretion

Absorption

Because of the low systemic absorption of pimecrolimus following topical application the calculation of standard pharmacokinetic measures such as AUC, Cmax, half-life, etc. cannot be reliably done.


Route of Elimination

80% of the drug is excreted in the feces.


5.6 Metabolism/Metabolites

No drug metabolism was observed in human skin in vitro. Oral administration yielded metabolites produced from O-demethylation and oxygenation reactions.


5.7 Mechanism of Action

Pimecrolimus binds with high affinity to macrophilin-12 (FKBP-12) and inhibits the calcium-dependent phosphatase, calcineurin. As a consequence, it inhibits T cell activation by blocking the transcription of early cytokines. In particular, pimecrolimus inhibits at nanomolar concentrations Interleukin-2 and interferon gamma (Th1-type) and Interleukin-4 and Interleukin-10 (Th2-type) cytokine synthesis in human T cells. Also, pimecrolimus prevents the release of inflammatory cytokines and mediators from mast cells in vitro after stimulation by antigen/lgE.


API SUPPLIERS

read-more
read-more

01

Synnat Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Synnat

02

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

03

Gonane Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Gonane Pharma

04

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU arrow-down AUDIT
HRV Global Life Sciences

05

Shanghai Minbiotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Shanghai Minbiotech CB

06

Fishfa Biogenics

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Fishfa Biogenics

07

Sumar Biotech

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
Sumar Biotech

08

Concord Biotech

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Concord Biotech

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT arrow-down
blank

09

BrightGene Bio-Medical Technology ...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

BrightGene Bio-Medical Technology ...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

10

Medichem S.A

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Medichem S.A

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT arrow-down
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Biocon Ltd

India

USDMF

arrow
AACR Annual meeting
Not Confirmed

01

Biocon Ltd

India
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2015-12-18

Pay. Date : 2014-12-30

DMF Number : 29390

Submission : 2015-09-30

Status : Active

Type : II

blank

02

AACR Annual meeting
Not Confirmed

02

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2016-03-03

Pay. Date : 2016-01-21

DMF Number : 30090

Submission : 2015-12-30

Status : Active

Type : II

blank

03

Concord Biotech Ltd

India

USDMF

arrow
AACR Annual meeting
Not Confirmed

03

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2015-11-23

Pay. Date : 2015-09-02

DMF Number : 29658

Submission : 2015-09-15

Status : Active

Type : II

blank

04

Medichem Sa

Spain

USDMF

arrow
AACR Annual meeting
Not Confirmed

04

Medichem Sa

Spain
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2015-10-07

Pay. Date : 2015-07-15

DMF Number : 29481

Submission : 2015-07-15

Status : Active

Type : II

blank

05

AACR Annual meeting
Not Confirmed

05

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 41946

Submission : 2025-09-19

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.

Flag India
Digital Content Digital Content

Pimecrolimus IHS

Date of Issue : 2023-09-29

Valid Till : 2026-09-28

Written Confirmation Number : WC-0570

Address of the Firm : Plot No. 112, 113, 114, GIDC Estate Gozariya, Mehsana-382825, Gujarat, India

Sumar Biotech

02

Biocon

India
AACR Annual meeting
Not Confirmed
arrow

Biocon

India
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus IH

Date of Issue : 2025-09-24

Valid Till : 2028-07-02

Written Confirmation Number : WC-0109

Address of the Firm : 20th KM, Hosur Road, Electronics City, Bengaluru ? 560 100

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus IH

Date of Issue : 2025-11-04

Valid Till : 2028-07-02

Written Confirmation Number : WC-0111

Address of the Firm : Survay No. 1482-1486, Trasad Road, Dholka, Dist:- Ahmedabad-382225, Gujarat Stat...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

Flag India
Digital Content Digital Content

Pimecrolimus

About the Company : Synnat Pharma is a fast-growing pharmaceutical company focused on the development, identification, production, and distribution of phytochemicals and botanical extracts. Its APIs a...

Synnat Pharma is a fast-growing pharmaceutical company focused on the development, identification, production, and distribution of phytochemicals and botanical extracts. Its APIs are supplied to major drug formulators worldwide. Manufacturing is conducted in line with ICH cGMP guidelines using conventional and modern techniques for isolation, semi-synthesis, and purification. Synnat Pharma operates in semi-regulated and non-regulated markets and is expanding into regulated markets. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Synnat

02

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Pimecrolimus

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.

Flag India
Digital Content Digital Content

Pimecrolimus

About the Company : Gonane Pharma is a contract pharmaceutical company based in Gujarat, India, specializing in the manufacturing and marketing of corticosteroids, hormones, antivirals, and oncology p...

Gonane Pharma is a contract pharmaceutical company based in Gujarat, India, specializing in the manufacturing and marketing of corticosteroids, hormones, antivirals, and oncology products. The company is supported by a dedicated team and promoters with over 25 years of experience in manufacturing, product promotion, and regulatory audits across markets including the EU, Mexico, China, Korea, and Russia. Gonane Pharma is also engaged with Japanese customers and continues to expand into new markets. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Gonane Pharma

04

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Pimecrolimus

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
HRV Global Life Sciences

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content

Pimecrolimus

About the Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in...

Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Shanghai Minbiotech CB

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

Flag India
Digital Content Digital Content

Pimecrolimus

About the Company : Fishfa Biogenics, a division of Fishfa Rubbers Ltd., manufactures and supplies biological APIs. The company operates GLP labs and WHO-GMP-certified facilities, specializing in ferm...

Fishfa Biogenics, a division of Fishfa Rubbers Ltd., manufactures and supplies biological APIs. The company operates GLP labs and WHO-GMP-certified facilities, specializing in fermentation-based production, process development, and manufacturing. Its site includes microbial drug substance production, quality testing, and technical, regulatory, and IP support. Fishfa exports APIs such as Mupirocin and Tacrolimus to markets in Europe, Asia, the Middle East, South America, Russia, New Zealand, and the UK. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Fishfa Biogenics

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.

Flag India
Digital Content Digital Content

Pimecrolimus

About the Company : Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. Founded by young entrepreneurs and experienced research and manufac...

Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. Founded by young entrepreneurs and experienced research and manufacturing professionals, the company focuses on innovating and manufacturing semi-synthetic, synthetic, and fermentation-based APIs. Its R&D facility is equipped with advanced technology for synthesis, extraction, isolation, purification, and upstream fermentation, with active work in process chemistry for therapeutic molecules. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Sumar Biotech

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

About the Company : BRAWN is a WHO GMP & ISO 9001:2008 Certified company with state of the art plant located in Faridabad, some 30 kms from New Delhi. Spread over more than 125000 sq ft floor area, i...

BRAWN is a WHO GMP & ISO 9001:2008 Certified company with state of the art plant located in Faridabad, some 30 kms from New Delhi. Spread over more than 125000 sq ft floor area, it has three separate blocks to manufacture Non Beta, Cephalosporin & Penicillin products, manufacturing a large variety of finished formulations covering all dosage forms.
blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

About the Company : Hanways Chempharm Co., Limited, the former one is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We are engaged in supplying APIs, pharmaceutical intermediate...

Hanways Chempharm Co., Limited, the former one is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We are engaged in supplying APIs, pharmaceutical intermediates, and fine chemicals for worldwide markets. With decades of development, now we grow to a leading and outstanding company. We are not just a trading company, but a comprehensive solutions supplier. With our sound knowledge of pharmaceutical business, our advantage is to integrate resources and adapt to all different demands of markets. We are a young but dynamic and energetic company with high efficient and high flexible decision making system.
blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

About the Company : Murli Krishna Pharma Private Ltd. is a young and dynamic drug delivery systems (DDS) company in India that provides a range of effective solutions to optimize the delivery of pharm...

Murli Krishna Pharma Private Ltd. is a young and dynamic drug delivery systems (DDS) company in India that provides a range of effective solutions to optimize the delivery of pharmaceutical products.Our manufacturing plant is approved for GMP Compliance by the WHO and the European Union; Murli Krishna Pharma is equipped to undertake formulation development projects on oral NDDS.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

2care4

Denmark
AACR Annual meeting
Not Confirmed
arrow

2care4

Denmark
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 1%

Packaging :

Approval Date : 03-09-2010

Application Number : 28104713110

Regulatory Info : Prescription

Registration Country : Denmark

blank

02

Actavis Inc

Ireland
AACR Annual meeting
Not Confirmed
arrow

Actavis Inc

Ireland
arrow
AACR Annual meeting
Not Confirmed

PIMECROLIMUS

Brand Name : PIMECROLIMUS

Dosage Form : CREAM;TOPICAL

Dosage Strength : 1%

Packaging :

Approval Date : 2018-12-27

Application Number : 209345

Regulatory Info : RX

Registration Country : USA

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PIMECROLIMUS

Brand Name : ELIDEL

Dosage Form : CREAM;TOPICAL

Dosage Strength : 1%

Packaging :

Approval Date : 2001-12-13

Application Number : 21302

Regulatory Info : RX

Registration Country : USA

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PIMECROLIMUS

Brand Name : PIMECROLIMUS

Dosage Form : CREAM;TOPICAL

Dosage Strength : 1%

Packaging :

Approval Date : 2019-08-29

Application Number : 211769

Regulatory Info : RX

Registration Country : USA

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Pimecrolimus 1% 30G Cream Dermatological Use

Dosage Strength : cream derm 30 g 1%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name :

Dosage Form : Pellets For Capsule

Dosage Strength : 5%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

07

Viatris

U.S.A
AACR Annual meeting
Not Confirmed
arrow

Viatris

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10mg

Packaging :

Approval Date : 19/03/2003

Application Number : 55965

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

Viatris

U.S.A
AACR Annual meeting
Not Confirmed
arrow

Viatris

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10mg/g

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

09

Viatris

U.S.A
AACR Annual meeting
Not Confirmed
arrow

Viatris

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10mg/g

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

10

Viatris

U.S.A
AACR Annual meeting
Not Confirmed
arrow

Viatris

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10MG

Packaging :

Approval Date : 09-10-2002

Application Number : 65029

Regulatory Info : Authorized

Registration Country : Spain

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PIMECROLIMUS

Brand Name : PIMECROLIMUS

Dosage Form : CREAM;TOPICAL

Dosage Strength : 1%

Approval Date : 2018-12-27

Application Number : 209345

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

02

BAUSCH

Canada
AACR Annual meeting
Not Confirmed
arrow

BAUSCH

Canada
arrow
AACR Annual meeting
Not Confirmed

PIMECROLIMUS

Brand Name : ELIDEL

Dosage Form : CREAM;TOPICAL

Dosage Strength : 1%

Approval Date : 2001-12-13

Application Number : 21302

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

PIMECROLIMUS

Brand Name : PIMECROLIMUS

Dosage Form : CREAM;TOPICAL

Dosage Strength : 1%

Approval Date : 2019-08-29

Application Number : 211769

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

2Care4 Aps

Denmark
AACR Annual meeting
Not Confirmed
arrow

2Care4 Aps

Denmark
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 1%

Packaging :

Approval Date : 03-09-2010

Application Number : 28104713110

Regulatory Info : Prescription

Registration Country : Denmark

blank

02

2Care4 Aps

Denmark
AACR Annual meeting
Not Confirmed
arrow

2Care4 Aps

Denmark
arrow
AACR Annual meeting
Not Confirmed

Pimekrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10mg/g

Packaging :

Approval Date : 15-08-2018

Application Number : 2.02E+13

Regulatory Info : Deregistered

Registration Country : Sweden

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10mg/g

Packaging :

Approval Date : 25-11-2022

Application Number : 28106825122

Regulatory Info : Prescription

Registration Country : Denmark

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimekrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10mg/g

Packaging :

Approval Date : 31-08-2021

Application Number : 2.02E+13

Regulatory Info : Deregistered

Registration Country : Sweden

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Pimecrolimus 1% 30G Cream Dermatological Use

Dosage Strength : cream derm 30 g 1%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10mg

Packaging :

Approval Date : 19/03/2003

Application Number : 55965

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

Viatris AS

U.S.A
AACR Annual meeting
Not Confirmed
arrow

Viatris AS

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10mg/g

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10MG

Packaging :

Approval Date : 09-10-2002

Application Number : 65029

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Viatris Aps

U.S.A
AACR Annual meeting
Not Confirmed
arrow

Viatris Aps

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Pimecrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 1%

Packaging :

Approval Date : 15-03-2002

Application Number : 28103270001

Regulatory Info : Prescription

Registration Country : Denmark

blank

10

Viatris Ab

U.S.A
AACR Annual meeting
Not Confirmed
arrow

Viatris Ab

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Pimekrolimus

Brand Name : Elidel

Dosage Form : Cream

Dosage Strength : 10mg/g

Packaging :

Approval Date : 17-04-2003

Application Number : 2.00E+13

Regulatory Info : Approved

Registration Country : Sweden

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Topical

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Coating Systems & Additives

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Direct Compression

read-more
read-more

Taste Masking

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 137071-32-0 / Pimecrolimus API manufacturers, exporters & distributors?

Pimecrolimus manufacturers, exporters & distributors 1

84

PharmaCompass offers a list of Pimecrolimus API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Pimecrolimus manufacturer or Pimecrolimus supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pimecrolimus manufacturer or Pimecrolimus supplier.

API | Excipient name

Pimecrolimus

Synonyms

Elidel, 137071-32-0, Sdz-asm 981, Sdz-asm-981, Sdz asm 981, 33-epi-chloro-33-desoxyascomycin

Cas Number

137071-32-0

Unique Ingredient Identifier (UNII)

7KYV510875

About Pimecrolimus

Pimecrolimus is a 33-epi-chloro-derivative of the ascomycin macrolactam with immunosuppressant property. Pimecrolimus binds to the receptor macrophilin-12 (FKBP-12) forming a complex that blocks the calcium-dependent signal transduction cascade mediated by calcineurin. Via dephosphorylation, calcineurin is the enzyme responsible for activating nuclear factor of activated T-cells (NF-AT), a T cell transcriptional regulatory factor. As a consequence, the synthesis and release of Th1- (T helper 1) and Th2- (T helper 2) type cytokines, and other inflammatory mediators from T-cells and mast cells are blocked and the expression of signals essential for the activation of inflammatory T-lymphocytes is inhibited. However, pimecrolimus mode of action is cell-selective and does not affect Langerhans' cells/dendritic cells and primary fibroblasts.

Elidel Manufacturers

A Elidel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elidel, including repackagers and relabelers. The FDA regulates Elidel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elidel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Elidel manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Elidel Suppliers

A Elidel supplier is an individual or a company that provides Elidel active pharmaceutical ingredient (API) or Elidel finished formulations upon request. The Elidel suppliers may include Elidel API manufacturers, exporters, distributors and traders.

click here to find a list of Elidel suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Elidel USDMF

A Elidel DMF (Drug Master File) is a document detailing the whole manufacturing process of Elidel active pharmaceutical ingredient (API) in detail. Different forms of Elidel DMFs exist exist since differing nations have different regulations, such as Elidel USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Elidel DMF submitted to regulatory agencies in the US is known as a USDMF. Elidel USDMF includes data on Elidel's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Elidel USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Elidel suppliers with USDMF on PharmaCompass.

Elidel KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Elidel Drug Master File in Korea (Elidel KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Elidel. The MFDS reviews the Elidel KDMF as part of the drug registration process and uses the information provided in the Elidel KDMF to evaluate the safety and efficacy of the drug.

After submitting a Elidel KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Elidel API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Elidel suppliers with KDMF on PharmaCompass.

Elidel WC

A Elidel written confirmation (Elidel WC) is an official document issued by a regulatory agency to a Elidel manufacturer, verifying that the manufacturing facility of a Elidel active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Elidel APIs or Elidel finished pharmaceutical products to another nation, regulatory agencies frequently require a Elidel WC (written confirmation) as part of the regulatory process.

click here to find a list of Elidel suppliers with Written Confirmation (WC) on PharmaCompass.

Elidel NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Elidel as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Elidel API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Elidel as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Elidel and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Elidel NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Elidel suppliers with NDC on PharmaCompass.

Elidel GMP

Elidel Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Elidel GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Elidel GMP manufacturer or Elidel GMP API supplier for your needs.

Elidel CoA

A Elidel CoA (Certificate of Analysis) is a formal document that attests to Elidel's compliance with Elidel specifications and serves as a tool for batch-level quality control.

Elidel CoA mostly includes findings from lab analyses of a specific batch. For each Elidel CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Elidel may be tested according to a variety of international standards, such as European Pharmacopoeia (Elidel EP), Elidel JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elidel USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty